Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma.

Discov Oncol · 2025 · PMC12559507 · PMID 41144123

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant

AURKA showed a positive expression rate of 30% (3/10) in EC tissues versus 10% (1/10) in normal tissues; however, this difference did not reach statistical significance ( P > 0.05) (Fig. 6 A and E).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.